Mary L. Rotunno

Insider Reports History

Entity
Individual
Location
C/O Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary L. Rotunno:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Director Stock Option (Right to Buy) 14.1K Sep 6, 2024 Direct

Insider Reports Filed by Mary L. Rotunno

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN Vistagen Therapeutics, Inc. Sep 6, 2024 1 $0 4 Sep 10, 2024 Director
VTGN Vistagen Therapeutics, Inc. Mar 4, 2024 1 $0 4 Mar 6, 2024 Director
VTGN VistaGen Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Director
VTGN VistaGen Therapeutics, Inc. Jul 6, 2021 1 $0 4 Jul 7, 2021 Director
VTGN VistaGen Therapeutics, Inc. Jul 6, 2021 0 $0 3 Jul 7, 2021 Director